Crossmark

The SHINE trial (a multicentre, randomised trial of stabilisation with nasal high flow during neonatal endotracheal intubation): statistical analysis plan

Crossref DOI link: https://doi.org/10.1186/s13063-021-05390-7

Published Online: 2021-08-24

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hodgson, Kate https://orcid.org/0000-0002-2908-1049
Manley, Brett

Kamlin, Omar

Owen, Louise

Roberts, Calum

Francis, Kate

Davis, Peter

Donath, Susan
Funding

Funding for this research was provided by:

National Health and Medical Research Council

Vapotherm (Provided equipment for trial)
License Information

Text and Data Mining valid from 2021-08-24

Version of Record valid from 2021-08-24
More Information

Article History

Received: 1 April 2021

Accepted: 21 June 2021

First Online: 24 August 2021

Declarations

:

: The SHINE trial was registered with the Australian and New Zealand Clinical Trials Registry (ACTRN126128001498280) on 6 September 2018. The trial was approved by the Human Research Ethics Committee of The Royal Women’s Hospital (Melbourne, Australia) on 8 November 2018 and by the Human Research Ethics Committee of Monash Health (Melbourne, Australia) on 1 March 2019.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below